GMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Gemini Therapeutics, Inc. Is Fair to Shareholders

NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Gemini Therapeutics, Inc. (NASDAQ: GMTX) and Disc Medicine, Inc. is fair to Gemini shareholders. Pre-merger Gemini shareholders are expected to own approximately 28% of the combined company.

Halper Sadeh encourages Gemini shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The investigation concerns whether Gemini and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Gemini shareholders; and (2) disclose all material information necessary for Gemini shareholders to adequately assess and value the merger consideration. On behalf of Gemini shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.
Contacts
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.comzhalper@halpersadeh.comhttps://www.halpersadeh.com